Tumours in the stomach are also called stomach tumours or abdominal tumours. When the accumulation of abnormal cells present in the stomach leads to abnormal growth of tissue, a tumour is formed ...
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...